Ken Griffin’s Citadel bets £300mn against drugmaker GSK
Hedge fund Citadel has made a £305mn bet against drugmaker GSK, the biggest short position against the company in more than a decade.
A microchip material maker sees its worst day in 11 years. Ken Griffin’s Citadel wins big.
A microchip materials manufacturer that counts Taiwan Semiconductor, GlobalFoundries and STMicroelectronics as clients saw ...
PRESS: Ken Griffin's Citadel bets GBP300 million against GSK - FT
(Alliance News) - Hedge fund Citadel has made a GBP305 million bet against pharmaceuticals firm GSK PLC, the biggest short position against the company in more than a decade, according to the ...
Ken Griffin's mutistrategy hedge fund at Citadel rose 1.4% in volatile January
Citadel's multistrategy flagship Wellington fund climbed 1.4% in January, following a 15.1% gain in 2024, according to the ...
Citadel's Griffin sees tariffs posing risk to US growth
Ken Griffin, founder and CEO of investment firm Citadel, said on Tuesday that U.S. President Donald Trump's tariff policy is ...
Citadel’s Ken Griffin says Trump's 'bombastic' trade rhetoric has already caused damage
Citadel CEO Ken Griffin had some strong words about the harmful effects of U.S. President Donald Trump's tariffs. Read more here.
Investing3d
Citadel's Ken Griffin voices criticism of Trump tariffs, praises Elon Musk's efforts
Griffin voiced his concern over Trump's approach towards tariffs, stating that the "bombastic rhetoric" has already caused ...
AOL3d
Citadel's Griffin on Trump tariff talk: 'It's a huge mistake'
Hedge fund billionaire Ken Griffin doesn't sound happy with Donald Trump's tariff policies. The founder and CEO of investment firm Citadel on Tuesday called aggressive trade talk from the new ...